nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—ABCB1—Ezetimibe—atherosclerosis	0.0528	0.267	CbGbCtD
Alitretinoin—ABCB1—Simvastatin—atherosclerosis	0.0491	0.248	CbGbCtD
Alitretinoin—ABCB1—Pravastatin—atherosclerosis	0.048	0.243	CbGbCtD
Alitretinoin—ABCB1—Lovastatin—atherosclerosis	0.048	0.243	CbGbCtD
Alitretinoin—CRABP1—connective tissue—atherosclerosis	0.000988	0.14	CbGeAlD
Alitretinoin—CRABP2—connective tissue—atherosclerosis	0.000893	0.127	CbGeAlD
Alitretinoin—CRABP2—adipose tissue—atherosclerosis	0.000685	0.0972	CbGeAlD
Alitretinoin—RXRG—cardiovascular system—atherosclerosis	0.000679	0.0963	CbGeAlD
Alitretinoin—RXRG—adipose tissue—atherosclerosis	0.000599	0.085	CbGeAlD
Alitretinoin—RARG—adipose tissue—atherosclerosis	0.0005	0.0709	CbGeAlD
Alitretinoin—Vision blurred—Lovastatin—atherosclerosis	0.000492	0.00113	CcSEcCtD
Alitretinoin—Mental disorder—Simvastatin—atherosclerosis	0.000492	0.00113	CcSEcCtD
Alitretinoin—Tremor—Lovastatin—atherosclerosis	0.000489	0.00112	CcSEcCtD
Alitretinoin—Visual impairment—Pravastatin—atherosclerosis	0.000489	0.00112	CcSEcCtD
Alitretinoin—Erythema—Simvastatin—atherosclerosis	0.000489	0.00112	CcSEcCtD
Alitretinoin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000485	0.00111	CcSEcCtD
Alitretinoin—Eye disorder—Niacin—atherosclerosis	0.000482	0.0011	CcSEcCtD
Alitretinoin—Flatulence—Simvastatin—atherosclerosis	0.000481	0.0011	CcSEcCtD
Alitretinoin—Tinnitus—Niacin—atherosclerosis	0.000481	0.0011	CcSEcCtD
Alitretinoin—Erythema multiforme—Pravastatin—atherosclerosis	0.00048	0.0011	CcSEcCtD
Alitretinoin—RXRA—liver—atherosclerosis	0.000479	0.0679	CbGeAlD
Alitretinoin—Flushing—Niacin—atherosclerosis	0.000478	0.00109	CcSEcCtD
Alitretinoin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000475	0.00109	CcSEcCtD
Alitretinoin—Anaemia—Ezetimibe—atherosclerosis	0.000474	0.00108	CcSEcCtD
Alitretinoin—Tinnitus—Pravastatin—atherosclerosis	0.000473	0.00108	CcSEcCtD
Alitretinoin—Malaise—Lovastatin—atherosclerosis	0.000471	0.00108	CcSEcCtD
Alitretinoin—Flushing—Pravastatin—atherosclerosis	0.000471	0.00108	CcSEcCtD
Alitretinoin—RARA—adipose tissue—atherosclerosis	0.00047	0.0667	CbGeAlD
Alitretinoin—Angiopathy—Niacin—atherosclerosis	0.000468	0.00107	CcSEcCtD
Alitretinoin—Chills—Niacin—atherosclerosis	0.000462	0.00106	CcSEcCtD
Alitretinoin—Malaise—Ezetimibe—atherosclerosis	0.000462	0.00106	CcSEcCtD
Alitretinoin—Vision blurred—Simvastatin—atherosclerosis	0.000461	0.00105	CcSEcCtD
Alitretinoin—Arrhythmia—Niacin—atherosclerosis	0.00046	0.00105	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000458	0.00105	CcSEcCtD
Alitretinoin—Tremor—Simvastatin—atherosclerosis	0.000458	0.00105	CcSEcCtD
Alitretinoin—Alopecia—Niacin—atherosclerosis	0.000455	0.00104	CcSEcCtD
Alitretinoin—Chills—Pravastatin—atherosclerosis	0.000455	0.00104	CcSEcCtD
Alitretinoin—Insomnia—Rosuvastatin—atherosclerosis	0.000455	0.00104	CcSEcCtD
Alitretinoin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000453	0.00104	CcSEcCtD
Alitretinoin—Arrhythmia—Pravastatin—atherosclerosis	0.000453	0.00104	CcSEcCtD
Alitretinoin—Palpitations—Ezetimibe—atherosclerosis	0.000453	0.00104	CcSEcCtD
Alitretinoin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000452	0.00103	CcSEcCtD
Alitretinoin—Anaemia—Simvastatin—atherosclerosis	0.000452	0.00103	CcSEcCtD
Alitretinoin—Erythema—Niacin—atherosclerosis	0.000449	0.00103	CcSEcCtD
Alitretinoin—Malnutrition—Niacin—atherosclerosis	0.000449	0.00103	CcSEcCtD
Alitretinoin—Alopecia—Pravastatin—atherosclerosis	0.000448	0.00103	CcSEcCtD
Alitretinoin—Cough—Ezetimibe—atherosclerosis	0.000447	0.00102	CcSEcCtD
Alitretinoin—Myalgia—Lovastatin—atherosclerosis	0.000445	0.00102	CcSEcCtD
Alitretinoin—Chest pain—Lovastatin—atherosclerosis	0.000445	0.00102	CcSEcCtD
Alitretinoin—Arthralgia—Lovastatin—atherosclerosis	0.000445	0.00102	CcSEcCtD
Alitretinoin—Anxiety—Lovastatin—atherosclerosis	0.000443	0.00101	CcSEcCtD
Alitretinoin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000443	0.00101	CcSEcCtD
Alitretinoin—Hypertension—Ezetimibe—atherosclerosis	0.000442	0.00101	CcSEcCtD
Alitretinoin—Flatulence—Niacin—atherosclerosis	0.000442	0.00101	CcSEcCtD
Alitretinoin—Malaise—Simvastatin—atherosclerosis	0.000441	0.00101	CcSEcCtD
Alitretinoin—Tension—Niacin—atherosclerosis	0.00044	0.00101	CcSEcCtD
Alitretinoin—Discomfort—Lovastatin—atherosclerosis	0.000439	0.00101	CcSEcCtD
Alitretinoin—Chest pain—Ezetimibe—atherosclerosis	0.000436	0.000998	CcSEcCtD
Alitretinoin—Myalgia—Ezetimibe—atherosclerosis	0.000436	0.000998	CcSEcCtD
Alitretinoin—Arthralgia—Ezetimibe—atherosclerosis	0.000436	0.000998	CcSEcCtD
Alitretinoin—Nervousness—Niacin—atherosclerosis	0.000436	0.000997	CcSEcCtD
Alitretinoin—Flatulence—Pravastatin—atherosclerosis	0.000435	0.000996	CcSEcCtD
Alitretinoin—Dry mouth—Lovastatin—atherosclerosis	0.000435	0.000995	CcSEcCtD
Alitretinoin—Tension—Pravastatin—atherosclerosis	0.000434	0.000992	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000433	0.000991	CcSEcCtD
Alitretinoin—Discomfort—Ezetimibe—atherosclerosis	0.000431	0.000986	CcSEcCtD
Alitretinoin—Constipation—Rosuvastatin—atherosclerosis	0.00043	0.000985	CcSEcCtD
Alitretinoin—Pain—Rosuvastatin—atherosclerosis	0.00043	0.000985	CcSEcCtD
Alitretinoin—Confusional state—Lovastatin—atherosclerosis	0.00043	0.000984	CcSEcCtD
Alitretinoin—RARB—liver—atherosclerosis	0.00043	0.061	CbGeAlD
Alitretinoin—Nervousness—Pravastatin—atherosclerosis	0.000429	0.000982	CcSEcCtD
Alitretinoin—Dry mouth—Ezetimibe—atherosclerosis	0.000427	0.000976	CcSEcCtD
Alitretinoin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000426	0.000976	CcSEcCtD
Alitretinoin—Infection—Lovastatin—atherosclerosis	0.000424	0.000969	CcSEcCtD
Alitretinoin—Vision blurred—Niacin—atherosclerosis	0.000423	0.000968	CcSEcCtD
Alitretinoin—Confusional state—Ezetimibe—atherosclerosis	0.000422	0.000965	CcSEcCtD
Alitretinoin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000418	0.000957	CcSEcCtD
Alitretinoin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000417	0.000955	CcSEcCtD
Alitretinoin—Vision blurred—Pravastatin—atherosclerosis	0.000416	0.000953	CcSEcCtD
Alitretinoin—Arthralgia—Simvastatin—atherosclerosis	0.000416	0.000952	CcSEcCtD
Alitretinoin—Chest pain—Simvastatin—atherosclerosis	0.000416	0.000952	CcSEcCtD
Alitretinoin—Myalgia—Simvastatin—atherosclerosis	0.000416	0.000952	CcSEcCtD
Alitretinoin—Infection—Ezetimibe—atherosclerosis	0.000415	0.000951	CcSEcCtD
Alitretinoin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000415	0.000949	CcSEcCtD
Alitretinoin—Anxiety—Simvastatin—atherosclerosis	0.000415	0.000949	CcSEcCtD
Alitretinoin—Tremor—Pravastatin—atherosclerosis	0.000414	0.000947	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000411	0.000941	CcSEcCtD
Alitretinoin—Discomfort—Simvastatin—atherosclerosis	0.000411	0.000941	CcSEcCtD
Alitretinoin—Nervous system disorder—Ezetimibe—atherosclerosis	0.00041	0.000938	CcSEcCtD
Alitretinoin—Ill-defined disorder—Pravastatin—atherosclerosis	0.00041	0.000938	CcSEcCtD
Alitretinoin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000409	0.000937	CcSEcCtD
Alitretinoin—Anaemia—Pravastatin—atherosclerosis	0.000408	0.000934	CcSEcCtD
Alitretinoin—Anorexia—Lovastatin—atherosclerosis	0.000406	0.00093	CcSEcCtD
Alitretinoin—Skin disorder—Ezetimibe—atherosclerosis	0.000406	0.00093	CcSEcCtD
Alitretinoin—Syncope—Niacin—atherosclerosis	0.000402	0.000921	CcSEcCtD
Alitretinoin—Confusional state—Simvastatin—atherosclerosis	0.000402	0.00092	CcSEcCtD
Alitretinoin—Urticaria—Rosuvastatin—atherosclerosis	0.0004	0.000915	CcSEcCtD
Alitretinoin—Oedema—Simvastatin—atherosclerosis	0.000399	0.000913	CcSEcCtD
Alitretinoin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000399	0.000913	CcSEcCtD
Alitretinoin—Malaise—Pravastatin—atherosclerosis	0.000398	0.000912	CcSEcCtD
Alitretinoin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000398	0.00091	CcSEcCtD
Alitretinoin—Palpitations—Niacin—atherosclerosis	0.000396	0.000907	CcSEcCtD
Alitretinoin—Infection—Simvastatin—atherosclerosis	0.000396	0.000907	CcSEcCtD
Alitretinoin—RXRB—liver—atherosclerosis	0.000395	0.056	CbGeAlD
Alitretinoin—Loss of consciousness—Niacin—atherosclerosis	0.000394	0.000902	CcSEcCtD
Alitretinoin—Cough—Niacin—atherosclerosis	0.000392	0.000896	CcSEcCtD
Alitretinoin—Thrombocytopenia—Simvastatin—atherosclerosis	0.00039	0.000894	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000388	0.000889	CcSEcCtD
Alitretinoin—Insomnia—Lovastatin—atherosclerosis	0.000386	0.000882	CcSEcCtD
Alitretinoin—Cough—Pravastatin—atherosclerosis	0.000385	0.000882	CcSEcCtD
Alitretinoin—Paraesthesia—Lovastatin—atherosclerosis	0.000383	0.000876	CcSEcCtD
Alitretinoin—Myalgia—Niacin—atherosclerosis	0.000382	0.000874	CcSEcCtD
Alitretinoin—Arthralgia—Niacin—atherosclerosis	0.000382	0.000874	CcSEcCtD
Alitretinoin—Hypertension—Pravastatin—atherosclerosis	0.000381	0.000873	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000381	0.000872	CcSEcCtD
Alitretinoin—Anorexia—Simvastatin—atherosclerosis	0.00038	0.00087	CcSEcCtD
Alitretinoin—Dyspnoea—Lovastatin—atherosclerosis	0.00038	0.00087	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000379	0.000868	CcSEcCtD
Alitretinoin—Insomnia—Ezetimibe—atherosclerosis	0.000378	0.000866	CcSEcCtD
Alitretinoin—Arthralgia—Pravastatin—atherosclerosis	0.000376	0.000861	CcSEcCtD
Alitretinoin—Myalgia—Pravastatin—atherosclerosis	0.000376	0.000861	CcSEcCtD
Alitretinoin—Chest pain—Pravastatin—atherosclerosis	0.000376	0.000861	CcSEcCtD
Alitretinoin—Paraesthesia—Ezetimibe—atherosclerosis	0.000375	0.000859	CcSEcCtD
Alitretinoin—Dyspepsia—Lovastatin—atherosclerosis	0.000375	0.000859	CcSEcCtD
Alitretinoin—Anxiety—Pravastatin—atherosclerosis	0.000375	0.000858	CcSEcCtD
Alitretinoin—Dry mouth—Niacin—atherosclerosis	0.000374	0.000855	CcSEcCtD
Alitretinoin—Dyspnoea—Ezetimibe—atherosclerosis	0.000373	0.000853	CcSEcCtD
Alitretinoin—Discomfort—Pravastatin—atherosclerosis	0.000372	0.00085	CcSEcCtD
Alitretinoin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000371	0.000848	CcSEcCtD
Alitretinoin—Decreased appetite—Lovastatin—atherosclerosis	0.000371	0.000848	CcSEcCtD
Alitretinoin—Dyspepsia—Ezetimibe—atherosclerosis	0.000368	0.000842	CcSEcCtD
Alitretinoin—Fatigue—Lovastatin—atherosclerosis	0.000368	0.000841	CcSEcCtD
Alitretinoin—Oedema—Niacin—atherosclerosis	0.000366	0.000838	CcSEcCtD
Alitretinoin—Anaphylactic shock—Niacin—atherosclerosis	0.000366	0.000838	CcSEcCtD
Alitretinoin—Constipation—Lovastatin—atherosclerosis	0.000365	0.000834	CcSEcCtD
Alitretinoin—Pain—Lovastatin—atherosclerosis	0.000365	0.000834	CcSEcCtD
Alitretinoin—Confusional state—Pravastatin—atherosclerosis	0.000364	0.000832	CcSEcCtD
Alitretinoin—Decreased appetite—Ezetimibe—atherosclerosis	0.000364	0.000832	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000363	0.000831	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000361	0.000826	CcSEcCtD
Alitretinoin—Asthenia—Rosuvastatin—atherosclerosis	0.000361	0.000826	CcSEcCtD
Alitretinoin—Insomnia—Simvastatin—atherosclerosis	0.000361	0.000825	CcSEcCtD
Alitretinoin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000361	0.000825	CcSEcCtD
Alitretinoin—Oedema—Pravastatin—atherosclerosis	0.000361	0.000825	CcSEcCtD
Alitretinoin—Fatigue—Ezetimibe—atherosclerosis	0.000361	0.000825	CcSEcCtD
Alitretinoin—Shock—Niacin—atherosclerosis	0.00036	0.000824	CcSEcCtD
Alitretinoin—Infection—Pravastatin—atherosclerosis	0.000358	0.00082	CcSEcCtD
Alitretinoin—Paraesthesia—Simvastatin—atherosclerosis	0.000358	0.000819	CcSEcCtD
Alitretinoin—Pain—Ezetimibe—atherosclerosis	0.000358	0.000818	CcSEcCtD
Alitretinoin—Constipation—Ezetimibe—atherosclerosis	0.000358	0.000818	CcSEcCtD
Alitretinoin—Tachycardia—Niacin—atherosclerosis	0.000357	0.000818	CcSEcCtD
Alitretinoin—Pruritus—Rosuvastatin—atherosclerosis	0.000356	0.000815	CcSEcCtD
Alitretinoin—Skin disorder—Niacin—atherosclerosis	0.000356	0.000814	CcSEcCtD
Alitretinoin—Dyspnoea—Simvastatin—atherosclerosis	0.000356	0.000814	CcSEcCtD
Alitretinoin—Hyperhidrosis—Niacin—atherosclerosis	0.000354	0.00081	CcSEcCtD
Alitretinoin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000353	0.000808	CcSEcCtD
Alitretinoin—Feeling abnormal—Lovastatin—atherosclerosis	0.000351	0.000804	CcSEcCtD
Alitretinoin—Dyspepsia—Simvastatin—atherosclerosis	0.000351	0.000803	CcSEcCtD
Alitretinoin—Anorexia—Niacin—atherosclerosis	0.000349	0.000799	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000349	0.000798	CcSEcCtD
Alitretinoin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000349	0.000798	CcSEcCtD
Alitretinoin—Decreased appetite—Simvastatin—atherosclerosis	0.000347	0.000793	CcSEcCtD
Alitretinoin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000345	0.000789	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000344	0.000788	CcSEcCtD
Alitretinoin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000344	0.000788	CcSEcCtD
Alitretinoin—Fatigue—Simvastatin—atherosclerosis	0.000344	0.000787	CcSEcCtD
Alitretinoin—Anorexia—Pravastatin—atherosclerosis	0.000344	0.000786	CcSEcCtD
Alitretinoin—Hypotension—Niacin—atherosclerosis	0.000342	0.000783	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000342	0.000783	CcSEcCtD
Alitretinoin—Pain—Simvastatin—atherosclerosis	0.000341	0.00078	CcSEcCtD
Alitretinoin—Constipation—Simvastatin—atherosclerosis	0.000341	0.00078	CcSEcCtD
Alitretinoin—Urticaria—Lovastatin—atherosclerosis	0.000339	0.000775	CcSEcCtD
Alitretinoin—Body temperature increased—Lovastatin—atherosclerosis	0.000337	0.000771	CcSEcCtD
Alitretinoin—Abdominal pain—Lovastatin—atherosclerosis	0.000337	0.000771	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000334	0.000763	CcSEcCtD
Alitretinoin—Dizziness—Rosuvastatin—atherosclerosis	0.000333	0.000761	CcSEcCtD
Alitretinoin—Urticaria—Ezetimibe—atherosclerosis	0.000332	0.00076	CcSEcCtD
Alitretinoin—Insomnia—Niacin—atherosclerosis	0.000331	0.000758	CcSEcCtD
Alitretinoin—Body temperature increased—Ezetimibe—atherosclerosis	0.000331	0.000757	CcSEcCtD
Alitretinoin—Abdominal pain—Ezetimibe—atherosclerosis	0.000331	0.000757	CcSEcCtD
Alitretinoin—RARA—liver—atherosclerosis	0.00033	0.0468	CbGeAlD
Alitretinoin—Paraesthesia—Niacin—atherosclerosis	0.000329	0.000752	CcSEcCtD
Alitretinoin—Feeling abnormal—Simvastatin—atherosclerosis	0.000329	0.000752	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000328	0.000752	CcSEcCtD
Alitretinoin—Dyspnoea—Niacin—atherosclerosis	0.000326	0.000747	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000326	0.000746	CcSEcCtD
Alitretinoin—Insomnia—Pravastatin—atherosclerosis	0.000326	0.000746	CcSEcCtD
Alitretinoin—Somnolence—Niacin—atherosclerosis	0.000326	0.000745	CcSEcCtD
Alitretinoin—Paraesthesia—Pravastatin—atherosclerosis	0.000324	0.000741	CcSEcCtD
Alitretinoin—Dyspepsia—Niacin—atherosclerosis	0.000322	0.000738	CcSEcCtD
Alitretinoin—Dyspnoea—Pravastatin—atherosclerosis	0.000321	0.000736	CcSEcCtD
Alitretinoin—Decreased appetite—Niacin—atherosclerosis	0.000318	0.000728	CcSEcCtD
Alitretinoin—Dyspepsia—Pravastatin—atherosclerosis	0.000317	0.000726	CcSEcCtD
Alitretinoin—Rash—Rosuvastatin—atherosclerosis	0.000317	0.000726	CcSEcCtD
Alitretinoin—Dermatitis—Rosuvastatin—atherosclerosis	0.000317	0.000725	CcSEcCtD
Alitretinoin—Urticaria—Simvastatin—atherosclerosis	0.000317	0.000725	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000316	0.000723	CcSEcCtD
Alitretinoin—Body temperature increased—Simvastatin—atherosclerosis	0.000315	0.000721	CcSEcCtD
Alitretinoin—Abdominal pain—Simvastatin—atherosclerosis	0.000315	0.000721	CcSEcCtD
Alitretinoin—Headache—Rosuvastatin—atherosclerosis	0.000315	0.000721	CcSEcCtD
Alitretinoin—Hypersensitivity—Lovastatin—atherosclerosis	0.000314	0.000719	CcSEcCtD
Alitretinoin—Decreased appetite—Pravastatin—atherosclerosis	0.000313	0.000717	CcSEcCtD
Alitretinoin—Pain—Niacin—atherosclerosis	0.000313	0.000717	CcSEcCtD
Alitretinoin—Fatigue—Pravastatin—atherosclerosis	0.000311	0.000711	CcSEcCtD
Alitretinoin—Constipation—Pravastatin—atherosclerosis	0.000308	0.000706	CcSEcCtD
Alitretinoin—Pain—Pravastatin—atherosclerosis	0.000308	0.000706	CcSEcCtD
Alitretinoin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000308	0.000705	CcSEcCtD
Alitretinoin—Asthenia—Lovastatin—atherosclerosis	0.000306	0.0007	CcSEcCtD
Alitretinoin—Pruritus—Lovastatin—atherosclerosis	0.000302	0.00069	CcSEcCtD
Alitretinoin—Asthenia—Ezetimibe—atherosclerosis	0.0003	0.000687	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Niacin—atherosclerosis	0.000299	0.000685	CcSEcCtD
Alitretinoin—Nausea—Rosuvastatin—atherosclerosis	0.000299	0.000684	CcSEcCtD
Alitretinoin—Feeling abnormal—Pravastatin—atherosclerosis	0.000297	0.00068	CcSEcCtD
Alitretinoin—Pruritus—Ezetimibe—atherosclerosis	0.000296	0.000677	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000295	0.000675	CcSEcCtD
Alitretinoin—Hypersensitivity—Simvastatin—atherosclerosis	0.000294	0.000672	CcSEcCtD
Alitretinoin—Diarrhoea—Lovastatin—atherosclerosis	0.000292	0.000668	CcSEcCtD
Alitretinoin—Urticaria—Niacin—atherosclerosis	0.000291	0.000666	CcSEcCtD
Alitretinoin—Abdominal pain—Niacin—atherosclerosis	0.000289	0.000662	CcSEcCtD
Alitretinoin—Body temperature increased—Niacin—atherosclerosis	0.000289	0.000662	CcSEcCtD
Alitretinoin—Urticaria—Pravastatin—atherosclerosis	0.000286	0.000655	CcSEcCtD
Alitretinoin—Asthenia—Simvastatin—atherosclerosis	0.000286	0.000655	CcSEcCtD
Alitretinoin—Diarrhoea—Ezetimibe—atherosclerosis	0.000286	0.000655	CcSEcCtD
Alitretinoin—Body temperature increased—Pravastatin—atherosclerosis	0.000285	0.000652	CcSEcCtD
Alitretinoin—Abdominal pain—Pravastatin—atherosclerosis	0.000285	0.000652	CcSEcCtD
Alitretinoin—Pruritus—Simvastatin—atherosclerosis	0.000282	0.000646	CcSEcCtD
Alitretinoin—Dizziness—Lovastatin—atherosclerosis	0.000282	0.000645	CcSEcCtD
Alitretinoin—Dizziness—Ezetimibe—atherosclerosis	0.000277	0.000633	CcSEcCtD
Alitretinoin—Diarrhoea—Simvastatin—atherosclerosis	0.000273	0.000624	CcSEcCtD
Alitretinoin—Vomiting—Lovastatin—atherosclerosis	0.000271	0.00062	CcSEcCtD
Alitretinoin—Hypersensitivity—Niacin—atherosclerosis	0.00027	0.000617	CcSEcCtD
Alitretinoin—Rash—Lovastatin—atherosclerosis	0.000269	0.000615	CcSEcCtD
Alitretinoin—Dermatitis—Lovastatin—atherosclerosis	0.000269	0.000615	CcSEcCtD
Alitretinoin—Headache—Lovastatin—atherosclerosis	0.000267	0.000611	CcSEcCtD
Alitretinoin—Vomiting—Ezetimibe—atherosclerosis	0.000266	0.000608	CcSEcCtD
Alitretinoin—Hypersensitivity—Pravastatin—atherosclerosis	0.000266	0.000608	CcSEcCtD
Alitretinoin—Dizziness—Simvastatin—atherosclerosis	0.000264	0.000603	CcSEcCtD
Alitretinoin—Rash—Ezetimibe—atherosclerosis	0.000264	0.000603	CcSEcCtD
Alitretinoin—Dermatitis—Ezetimibe—atherosclerosis	0.000263	0.000603	CcSEcCtD
Alitretinoin—Asthenia—Niacin—atherosclerosis	0.000263	0.000601	CcSEcCtD
Alitretinoin—Headache—Ezetimibe—atherosclerosis	0.000262	0.0006	CcSEcCtD
Alitretinoin—Pruritus—Niacin—atherosclerosis	0.000259	0.000593	CcSEcCtD
Alitretinoin—Asthenia—Pravastatin—atherosclerosis	0.000259	0.000592	CcSEcCtD
Alitretinoin—Pruritus—Pravastatin—atherosclerosis	0.000255	0.000584	CcSEcCtD
Alitretinoin—Vomiting—Simvastatin—atherosclerosis	0.000254	0.00058	CcSEcCtD
Alitretinoin—Nausea—Lovastatin—atherosclerosis	0.000253	0.00058	CcSEcCtD
Alitretinoin—Rash—Simvastatin—atherosclerosis	0.000251	0.000575	CcSEcCtD
Alitretinoin—Dermatitis—Simvastatin—atherosclerosis	0.000251	0.000575	CcSEcCtD
Alitretinoin—Diarrhoea—Niacin—atherosclerosis	0.000251	0.000573	CcSEcCtD
Alitretinoin—Headache—Simvastatin—atherosclerosis	0.00025	0.000572	CcSEcCtD
Alitretinoin—Nausea—Ezetimibe—atherosclerosis	0.000248	0.000568	CcSEcCtD
Alitretinoin—Diarrhoea—Pravastatin—atherosclerosis	0.000247	0.000565	CcSEcCtD
Alitretinoin—Dizziness—Niacin—atherosclerosis	0.000242	0.000554	CcSEcCtD
Alitretinoin—Dizziness—Pravastatin—atherosclerosis	0.000238	0.000546	CcSEcCtD
Alitretinoin—Nausea—Simvastatin—atherosclerosis	0.000237	0.000542	CcSEcCtD
Alitretinoin—Vomiting—Niacin—atherosclerosis	0.000233	0.000533	CcSEcCtD
Alitretinoin—Rash—Niacin—atherosclerosis	0.000231	0.000528	CcSEcCtD
Alitretinoin—Dermatitis—Niacin—atherosclerosis	0.000231	0.000528	CcSEcCtD
Alitretinoin—Headache—Niacin—atherosclerosis	0.000229	0.000525	CcSEcCtD
Alitretinoin—Vomiting—Pravastatin—atherosclerosis	0.000229	0.000525	CcSEcCtD
Alitretinoin—Rash—Pravastatin—atherosclerosis	0.000227	0.00052	CcSEcCtD
Alitretinoin—Dermatitis—Pravastatin—atherosclerosis	0.000227	0.00052	CcSEcCtD
Alitretinoin—ABCB1—blood vessel—atherosclerosis	0.000227	0.0322	CbGeAlD
Alitretinoin—Headache—Pravastatin—atherosclerosis	0.000226	0.000517	CcSEcCtD
Alitretinoin—Nausea—Niacin—atherosclerosis	0.000218	0.000498	CcSEcCtD
Alitretinoin—Nausea—Pravastatin—atherosclerosis	0.000214	0.00049	CcSEcCtD
Alitretinoin—CYP1A2—liver—atherosclerosis	0.000122	0.0173	CbGeAlD
Alitretinoin—ABCB1—cardiovascular system—atherosclerosis	0.000101	0.0144	CbGeAlD
Alitretinoin—ABCB1—adipose tissue—atherosclerosis	8.93e-05	0.0127	CbGeAlD
Alitretinoin—ABCB1—liver—atherosclerosis	6.26e-05	0.00888	CbGeAlD
Alitretinoin—RARB—Gene Expression—ESR1—atherosclerosis	4.92e-05	0.000137	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	4.86e-05	0.000136	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HSPA1B—atherosclerosis	4.8e-05	0.000134	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—BGN—atherosclerosis	4.77e-05	0.000133	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.74e-05	0.000132	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOA5—atherosclerosis	4.72e-05	0.000132	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ESR1—atherosclerosis	4.72e-05	0.000132	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—ESR1—atherosclerosis	4.72e-05	0.000132	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	4.71e-05	0.000131	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—atherosclerosis	4.66e-05	0.00013	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	4.66e-05	0.00013	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.59e-05	0.000128	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PPARG—atherosclerosis	4.58e-05	0.000128	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PLA2G1B—atherosclerosis	4.55e-05	0.000127	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	4.54e-05	0.000127	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—atherosclerosis	4.53e-05	0.000127	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—atherosclerosis	4.53e-05	0.000127	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	4.52e-05	0.000126	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—SERPINE1—atherosclerosis	4.51e-05	0.000126	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.5e-05	0.000126	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.5e-05	0.000126	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—atherosclerosis	4.49e-05	0.000125	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	4.48e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.45e-05	0.000124	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.44e-05	0.000124	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALOX5—atherosclerosis	4.39e-05	0.000123	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—atherosclerosis	4.38e-05	0.000122	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	4.38e-05	0.000122	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	4.38e-05	0.000122	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	4.35e-05	0.000122	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	4.32e-05	0.000121	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—atherosclerosis	4.3e-05	0.00012	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—atherosclerosis	4.3e-05	0.00012	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—INS—atherosclerosis	4.3e-05	0.00012	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	4.3e-05	0.00012	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PARP1—atherosclerosis	4.28e-05	0.00012	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.23e-05	0.000118	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	4.22e-05	0.000118	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—SERPINE1—atherosclerosis	4.2e-05	0.000117	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—SERPINE1—atherosclerosis	4.12e-05	0.000115	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	4.11e-05	0.000115	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.06e-05	0.000113	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ESR2—atherosclerosis	4.05e-05	0.000113	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—SERPINE1—atherosclerosis	4.04e-05	0.000113	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—atherosclerosis	4.03e-05	0.000113	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LDLRAP1—atherosclerosis	4.03e-05	0.000113	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP2—atherosclerosis	4.03e-05	0.000112	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NAMPT—atherosclerosis	3.94e-05	0.00011	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.92e-05	0.000109	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—LIPC—atherosclerosis	3.91e-05	0.000109	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	3.9e-05	0.000109	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOC3—atherosclerosis	3.89e-05	0.000109	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SERPINE1—atherosclerosis	3.88e-05	0.000108	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SERPINE1—atherosclerosis	3.88e-05	0.000108	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—LDLR—atherosclerosis	3.87e-05	0.000108	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLTP—atherosclerosis	3.79e-05	0.000106	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CETP—atherosclerosis	3.78e-05	0.000105	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.71e-05	0.000104	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	3.7e-05	0.000103	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	3.7e-05	0.000103	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	3.7e-05	0.000103	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	3.7e-05	0.000103	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	3.65e-05	0.000102	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SCARB1—atherosclerosis	3.62e-05	0.000101	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	3.55e-05	9.93e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	3.53e-05	9.86e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.52e-05	9.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	3.47e-05	9.68e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HMGCR—atherosclerosis	3.41e-05	9.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	3.38e-05	9.45e-05	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—atherosclerosis	3.35e-05	9.35e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCG8—atherosclerosis	3.29e-05	9.18e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LTA4H—atherosclerosis	3.29e-05	9.18e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SIRT1—atherosclerosis	3.26e-05	9.11e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.26e-05	9.1e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	3.22e-05	9e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	3.22e-05	8.99e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.15e-05	8.78e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.08e-05	8.6e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCA1—atherosclerosis	3.04e-05	8.5e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLTP—atherosclerosis	3.03e-05	8.45e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—atherosclerosis	3.03e-05	8.45e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NFKB1—atherosclerosis	2.99e-05	8.36e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	2.95e-05	8.23e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MAPK3—atherosclerosis	2.93e-05	8.19e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.84e-05	7.93e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.8e-05	7.83e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.79e-05	7.78e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.77e-05	7.73e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—atherosclerosis	2.72e-05	7.59e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARA—atherosclerosis	2.71e-05	7.58e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.7e-05	7.55e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—atherosclerosis	2.69e-05	7.51e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MAPK3—atherosclerosis	2.68e-05	7.49e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MAPK3—atherosclerosis	2.63e-05	7.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LTA4H—atherosclerosis	2.62e-05	7.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCG8—atherosclerosis	2.62e-05	7.33e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HMOX1—atherosclerosis	2.61e-05	7.29e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCG1—atherosclerosis	2.6e-05	7.25e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.59e-05	7.23e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK3—atherosclerosis	2.57e-05	7.18e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.56e-05	7.14e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MAPK3—atherosclerosis	2.52e-05	7.04e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MAPK3—atherosclerosis	2.52e-05	7.04e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.51e-05	7.02e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOB—atherosclerosis	2.5e-05	6.99e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—atherosclerosis	2.49e-05	6.96e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ESR1—atherosclerosis	2.46e-05	6.86e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.45e-05	6.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FABP4—atherosclerosis	2.44e-05	6.82e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LCAT—atherosclerosis	2.44e-05	6.82e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTM1—atherosclerosis	2.43e-05	6.79e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.41e-05	6.74e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOA4—atherosclerosis	2.4e-05	6.7e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—LPL—atherosclerosis	2.39e-05	6.67e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.36e-05	6.58e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GPX1—atherosclerosis	2.33e-05	6.51e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—atherosclerosis	2.33e-05	6.5e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.32e-05	6.48e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—atherosclerosis	2.28e-05	6.36e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—atherosclerosis	2.28e-05	6.36e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CD36—atherosclerosis	2.27e-05	6.34e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—atherosclerosis	2.24e-05	6.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.23e-05	6.22e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.2e-05	6.13e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.18e-05	6.09e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP27A1—atherosclerosis	2.18e-05	6.08e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—MTHFR—atherosclerosis	2.15e-05	6.01e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.13e-05	5.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.13e-05	5.95e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARA—atherosclerosis	2.11e-05	5.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCG1—atherosclerosis	2.07e-05	5.79e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLA2G2A—atherosclerosis	2.06e-05	5.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOA2—atherosclerosis	2.06e-05	5.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALOX15—atherosclerosis	2.06e-05	5.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALOX5AP—atherosclerosis	2.06e-05	5.76e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AGT—atherosclerosis	2.04e-05	5.71e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCG5—atherosclerosis	2.04e-05	5.69e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SERPINE1—atherosclerosis	2.02e-05	5.64e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOE—atherosclerosis	2e-05	5.59e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.99e-05	5.56e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CAV1—atherosclerosis	1.98e-05	5.54e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOA1—atherosclerosis	1.98e-05	5.53e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—atherosclerosis	1.98e-05	5.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LPA—atherosclerosis	1.97e-05	5.5e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FABP4—atherosclerosis	1.95e-05	5.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LCAT—atherosclerosis	1.95e-05	5.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOA4—atherosclerosis	1.91e-05	5.34e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BGN—atherosclerosis	1.91e-05	5.32e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOA5—atherosclerosis	1.89e-05	5.27e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.88e-05	5.25e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—atherosclerosis	1.88e-05	5.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.82e-05	5.07e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—atherosclerosis	1.81e-05	5.05e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CG—atherosclerosis	1.81e-05	5.05e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.8e-05	5.03e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.79e-05	5e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—atherosclerosis	1.77e-05	4.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALOX5—atherosclerosis	1.75e-05	4.9e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—atherosclerosis	1.74e-05	4.87e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.74e-05	4.85e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—atherosclerosis	1.73e-05	4.84e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.71e-05	4.78e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—INS—atherosclerosis	1.71e-05	4.78e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—atherosclerosis	1.7e-05	4.75e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—atherosclerosis	1.7e-05	4.75e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.69e-05	4.72e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.67e-05	4.66e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.65e-05	4.6e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.65e-05	4.6e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.65e-05	4.6e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOA2—atherosclerosis	1.65e-05	4.6e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.63e-05	4.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.63e-05	4.54e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NAMPT—atherosclerosis	1.57e-05	4.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LPA—atherosclerosis	1.57e-05	4.39e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—atherosclerosis	1.57e-05	4.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LIPC—atherosclerosis	1.56e-05	4.37e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOC3—atherosclerosis	1.55e-05	4.34e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LDLR—atherosclerosis	1.54e-05	4.31e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BGN—atherosclerosis	1.52e-05	4.25e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.51e-05	4.22e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CETP—atherosclerosis	1.51e-05	4.21e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOA5—atherosclerosis	1.51e-05	4.21e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NOS3—atherosclerosis	1.5e-05	4.19e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.48e-05	4.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.46e-05	4.09e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.45e-05	4.05e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SCARB1—atherosclerosis	1.44e-05	4.04e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.43e-05	4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.42e-05	3.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.42e-05	3.96e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.4e-05	3.91e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—atherosclerosis	1.37e-05	3.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMGCR—atherosclerosis	1.36e-05	3.81e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.34e-05	3.74e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MAPK3—atherosclerosis	1.31e-05	3.67e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.29e-05	3.61e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.26e-05	3.51e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.25e-05	3.49e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LIPC—atherosclerosis	1.25e-05	3.49e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOC3—atherosclerosis	1.24e-05	3.47e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LDLR—atherosclerosis	1.23e-05	3.44e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCA1—atherosclerosis	1.22e-05	3.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CETP—atherosclerosis	1.2e-05	3.36e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.15e-05	3.22e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.12e-05	3.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.09e-05	3.04e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMOX1—atherosclerosis	1.04e-05	2.91e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOB—atherosclerosis	1e-05	2.79e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.83e-06	2.74e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM1—atherosclerosis	9.72e-06	2.72e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCA1—atherosclerosis	9.71e-06	2.71e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LPL—atherosclerosis	9.54e-06	2.67e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPX1—atherosclerosis	9.31e-06	2.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CD36—atherosclerosis	9.07e-06	2.53e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—atherosclerosis	8.87e-06	2.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTHFR—atherosclerosis	8.59e-06	2.4e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARA—atherosclerosis	8.43e-06	2.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMOX1—atherosclerosis	8.33e-06	2.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AGT—atherosclerosis	8.16e-06	2.28e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOE—atherosclerosis	8e-06	2.23e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOB—atherosclerosis	7.98e-06	2.23e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CAV1—atherosclerosis	7.93e-06	2.21e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOA1—atherosclerosis	7.91e-06	2.21e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM1—atherosclerosis	7.76e-06	2.17e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LPL—atherosclerosis	7.62e-06	2.13e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPX1—atherosclerosis	7.43e-06	2.08e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CD36—atherosclerosis	7.24e-06	2.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CG—atherosclerosis	7.22e-06	2.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—atherosclerosis	6.97e-06	1.95e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—atherosclerosis	6.89e-06	1.93e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTHFR—atherosclerosis	6.86e-06	1.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—INS—atherosclerosis	6.83e-06	1.91e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARA—atherosclerosis	6.73e-06	1.88e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AGT—atherosclerosis	6.52e-06	1.82e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOE—atherosclerosis	6.39e-06	1.78e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CAV1—atherosclerosis	6.33e-06	1.77e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOA1—atherosclerosis	6.31e-06	1.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—atherosclerosis	6.27e-06	1.75e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NOS3—atherosclerosis	5.99e-06	1.67e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CG—atherosclerosis	5.76e-06	1.61e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—atherosclerosis	5.56e-06	1.55e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—atherosclerosis	5.48e-06	1.53e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—INS—atherosclerosis	5.46e-06	1.52e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—atherosclerosis	5e-06	1.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NOS3—atherosclerosis	4.78e-06	1.34e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.38e-06	1.22e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—atherosclerosis	2.76e-06	7.69e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—atherosclerosis	2.2e-06	6.14e-06	CbGpPWpGaD
